Raúl Córdoba

机构：Hospital Universitario Fundación Jiménez Díaz, Hospital General Universitario de Albacete · ORCID：0000-0002-7654-8836

发表论文 422 篇 · 总被引 8147 次 · h-index 37

代表论文

• Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma (2026 · Blood Advances · 被引 4)
• Fixed-duration epcoritamab + R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3–5) led to sustained remissions and disease-free survival beyond 3 years: Results from the EPCORE NHL-2 trial (2025 · Blood · 被引 4)
• Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry (2025 · American Journal of Hematology · 被引 2)
• Fixed-duration epcoritamab monotherapy induces high response and MRD-negativity rates in elderly patients with newly diagnosed large B-cell lymphoma (LBCL) and comorbidities: Results from EPCORE DLBCL-3 (2025 · Blood · 被引 2)
• Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry (2026 · Open Forum Infectious Diseases · 被引 1)
• Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data (2026 · Clinical Pharmacology & Therapeutics · 被引 1)